Literature DB >> 19411566

Hospital-at-home care for exacerbations of chronic obstructive pulmonary disease: an observational cohort study of patients managed in hospital or by nurse practitioners in the community.

K Ansari1, M Shamssain, M Farrow, N P Keaney.   

Abstract

The Urgent Care Team (UCT) in Sunderland (pop. 293,000) is a unique nurse practitioner service operating a hospital at home 24/7/365 to deal promptly with patients suffering an exacerbation of their COPD (AECOPD). Treatment is according to patient group directions utilising nebulised bronchodilators, doxycycline and prednisolone. To compare the health status and pathophysiology during and two months after an AECOPD in 60 UCT patients (31 male) and 30 hospital-managed patients (16 male). The St. Georges Respiratory Questionnaire (SGRQ), Mahler Baseline Dyspnoea Index (BDI) and MRC dyspnoea score recorded health status. Spirometry, BMI and grip strength were also measured. All patients were reviewed 2-3 months after the AECOPD. Changes from BDI were measured using the Transitional Dyspnoea Index (TDI). Mean FEV1% predicted was 47%. In the recovery phase the two groups were comparable for all variables. But during their AECOPD hospitalised patients had a significantly lower BDI (P < 0.05) and an oxygen saturation ranging from 84 to 93% compared with 87-96% for UCT patients. Paired t-tests indicated that on recovery SGRQ activity domain and TDI measures improved in both groups. No deaths occurred during these AECOPDs. A hospital-at-home scheme for AECOPDs can deal with patients who have severe COPD safely. The Mahler TDI appears to be a sensitive index of improvement after an AECOPD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411566     DOI: 10.1177/1479972309102728

Source DB:  PubMed          Journal:  Chron Respir Dis        ISSN: 1479-9723            Impact factor:   2.444


  6 in total

1.  Application of appropriateness criteria for hospitalization in COPD exacerbation.

Authors:  Susana Garcia-Gutierrez; José M Quintana; Irantzu Barrio; Marisa Bare; Nerea Fernandez; Silvia Vidal; Nerea Gonzalez; Iratxe Lafuente; Edurne Arteta; Cristóbal Esteban; Esther Pulido
Journal:  Intern Emerg Med       Date:  2013-03-19       Impact factor: 3.397

2.  Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Onno C P van Schayck; Walter van Litsenburg; Annet Janssen; Monique van Vliet; Wiel Seezink; Dirk R A J Demunck; Brigitte van de Pas; Peter J de Bruijn; Anouschka van der Pouw; Jeroen M A M Retera; Petra de Laat-Bierings; Loes van Eijsden; Maria Braken; Riet Eijsermans; Maureen P M H Rutten-van Mölken
Journal:  BMC Public Health       Date:  2010-10-18       Impact factor: 3.295

3.  The outcomes of nurse practitioner (NP)-Provided home visits: A systematic review.

Authors:  Zainab Toteh Osakwe; Sainfer Aliyu; Olukayode Ayodeji Sosina; Lusine Poghosyan
Journal:  Geriatr Nurs       Date:  2020-07-24       Impact factor: 2.361

4.  Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial.

Authors:  Cecile M A Utens; Lucas M A Goossens; Frank W J M Smeenk; Maureen P M H Rutten-van Mölken; Monique van Vliet; Maria W Braken; Loes M G A van Eijsden; Onno C P van Schayck
Journal:  BMJ Open       Date:  2012-10-16       Impact factor: 2.692

5.  Patients with acute exacerbation of chronic obstructive pulmonary disease feel safe when treated at home: a qualitative study.

Authors:  Ying Wang; Torbjørn Haugen; Sissel Steihaug; Anne Werner
Journal:  BMC Pulm Med       Date:  2012-08-24       Impact factor: 3.317

6.  Physician Assistants and Nurse Practitioners in Primary Care Plus: A Systematic Review.

Authors:  R M A van Erp; A L van Doorn; G T van den Brink; J W B Peters; M G H Laurant; A J van Vught
Journal:  Int J Integr Care       Date:  2021-02-12       Impact factor: 5.120

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.